3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
16
Burkitt Lymphoma
16
Prostatic Neoplasms
15
Lymphoma, Follicular
8
Lymphoma, Non-Hodgkin
7
Lymphoma
7
Neoplasms
6
Prostatic Neoplasms, Castration-Resistant
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, B-Cell, Marginal Zone
3
Lymphoma, B-Cell
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Lymphoproliferative Disorders
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Triple Negative Breast Neoplasms
1
Recurrence
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Multi-centric Castleman's Disease
1
Metastatic Castration-sensitive Prostate Cancer
1
Metastatic Castration-resistant Prostate Neoplasms
1
Melanoma
1
Macular dystrophy, corneal type 1
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphadenopathy
1
Interventions
X-Rays
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
Vincristine
3
Doxorubicin
3
Dactinomycin
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Radiotherapy, Conformal
2
Cyclophosphamide
2
tazemetostat
1
talazoparib
1
selinexor
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
cabozantinib
1
Vemurafenib
1
Temozolomide
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Wilms Tumor
×
Prednisone
×
30 days
×
Clear all
No trials found.